Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 1606 AL 1620

Parkinson's disease: no milk today?

Kistner A, Krack P.

Front Neurol. 2014 Sep 5;5:172. doi: 10.3389/fneur.2014.00172. eCollection 2014.

Use of Caenorhabditis elegans as a model to study Alzheimer's disease and other neurodegenerative diseases

Alexander AG, Marfil V, Li C.

Front Genet. 2014 Sep 5;5:279. doi: 10.3389/fgene.2014.00279. eCollection 2014.

Does anxiety cause freezing of gait in Parkinson's disease?

Ehgoetz Martens KA, Ellard CG, Almeida QJ.

PLoS One. 2014 Sep 24;9(9):e106561. doi: 10.1371/journal.pone.0106561. eCollection 2014.

LRRK2 pathobiology in Parkinson's disease

Martin I, Kim JW, Dawson VL, Dawson TM.

J Neurochem. 2014 Dec;131(5):554-65. doi: 10.1111/jnc.12949. Epub 2014 Oct 10.

Aerodynamic measures of glottal function: what extra can they tell us and how do they guide management?

Jiang JJ, Maytag AL.

Curr Opin Otolaryngol Head Neck Surg. 2014 Dec;22(6):450-4. doi: 10.1097/MOO.0000000000000107.

Understanding the role of heteroreceptor complexes in the central nervous system

Fuxe K, Borroto-Escuela D, Fisone G, Agnati LF, Tanganelli S.

Curr Protein Pept Sci. 2014;15(7):647. doi: 10.2174/138920371507140916122738.

Interactions between calcium and alpha-synuclein in neurodegeneration

Rcom-H'cheo-Gauthier A, Goodwin J, Pountney DL.

Biomolecules. 2014 Aug 14;4(3):795-811. doi: 10.3390/biom4030795.

Smartphone- and internet-assisted self-management and adherence tools to manage Parkinson's disease (SMART-PD): study protocol for a randomised controlled trial (v7; 15 August 2014)

Lakshminarayana R, Wang D, Burn D, Chaudhuri KR, Cummins G, Galtrey C, Hellman B, Pal S, Stamford J, Steiger M, Williams A; SMART-PD Investigators.

Trials. 2014 Sep 25;15:374. doi: 10.1186/1745-6215-15-374.

Bioactive compounds from macroalgae in the new millennium: implications for neurodegenerative diseases

Barbosa M, Valentão P, Andrade PB.

Mar Drugs. 2014 Sep 25;12(9):4934-72. doi: 10.3390/md12094934.

Mendelian randomization of serum urate and parkinson disease progression

Simon KC, Eberly S, Gao X, Oakes D, Tanner CM, Shoulson I, Fahn S, Schwarzschild MA, Ascherio A; Parkinson Study Group.

Ann Neurol. 2014 Dec;76(6):862-8. doi: 10.1002/ana.24281. Epub 2014 Oct 3.

Occurrence of Takotsubo syndrome in a patient with Parkinson's disease after entacapone add-on

Baldacci F, Vergallo A, Del Dotto P, Ulivi M, Palombo C, Casolo G, Tomei G, Bonuccelli U.

Parkinsonism Relat Disord. 2014 Nov;20(11):1313-4. doi: 10.1016/j.parkreldis.2014.09.009. Epub 2014 Sep 16.

Reduced alpha-synuclein in cerebrospinal fluid in synucleinopathies: evidence from a meta-analysis

Sako W, Murakami N, Izumi Y, Kaji R.

Mov Disord. 2014 Nov;29(13):1599-605. doi: 10.1002/mds.26036. Epub 2014 Sep 25.

Fetal stem cell transplantation: Past, present, and future

Ishii T, Eto K.

World J Stem Cells. 2014 Sep 26;6(4):404-20. doi: 10.4252/wjsc.v6.i4.404.

Brain network markers of abnormal cerebral glucose metabolism and blood flow in Parkinson's disease

Peng S, Eidelberg D, Ma Y.

Neurosci Bull. 2014 Oct;30(5):823-37. doi: 10.1007/s12264-014-1472-x. Epub 2014 Sep 28.

The cognition and emotional well-being indices of the Parkinson's disease questionnaire-39: what do they really measure?

Jones JD, Hass C, Mangal P, Lafo J, Okun MS, Bowers D.

Parkinsonism Relat Disord. 2014 Nov;20(11):1236-41. doi: 10.1016/j.parkreldis.2014.09.014. Epub 2014 Sep 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias